Raymond James Financial
DVAX

Raymond James Financial’s Dynavax Technologies DVAX Stock Holding History

Raymond James Financial’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,499
Closed -$192K – 5337
2025
Q4 		$192K Sell
12,499
-2,125
-15% -$23.4K ﹤0.01% 4799
2025
Q3 		$145K Buy
14,624
+128
+0.9% +$1.33K ﹤0.01% 4686
2025
Q2 		$144K Sell
14,496
-1,500
-9% -$15.8K ﹤0.01% 4687
2025
Q1 		$207K Buy
15,996
+949
+6% +$12.6K ﹤0.01% 4406
2024
Q4 		$192K Buy
+15,047
New +$182K ﹤0.01% 4415

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raymond James Financial's DVAX Position: Q1 2026 in Review

Raymond James Financial sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 12,499 shares — an estimated $192K sold.

Raymond James Financial first reported a position in DVAX in Q4 2024 and held it in 5 quarters. The position peaked at $207K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Raymond James Financial reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Raymond James Financial sold 12,499 Dynavax Technologies shares in Q1 2026, an estimated $192K.
  • Raymond James Financial first reported a position in Dynavax Technologies in Q4 2024 and held it in 5 quarters.
  • Raymond James Financial's Dynavax Technologies position peaked at $207K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.